<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01522573</url>
  </required_header>
  <id_info>
    <org_study_id>1111012016</org_study_id>
    <nct_id>NCT01522573</nct_id>
  </id_info>
  <brief_title>T-EUS for Gastrointestinal Disorders: A Multicenter Registry</brief_title>
  <acronym>EUSERCPReg</acronym>
  <official_title>Therapeutic Endoscopic Ultrasound (T-EUS) Guided Procedures in the Management of Gastrointestinal Disorders: A Multicenter Registry.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to record information and evaluate the impact of Endoscopic
      Ultrasound (EUS) Guided Endoscopic retrograde cholangiopancreatography (ERCP) on the
      management of pancreatico-biliary disorders. The registry will evaluate efficacy, safety and
      technical success of the Endoscopic Ultrasound (EUS)Guided Endoscopic retrograde
      cholangiopancreatography (ERCP) procedures. The safety and efficacy of various EUS-Guided
      ERCP procedures have been assessed in a series of studies.

      This multi-center registry has been initiated:

        -  To document the impact of EUS-Guided ERCP procedures on the management of
           pancreatico-biliary disorders including malignancies.

        -  To assess the clinical and technical success rates of EUS-Guided ERCPs for diagnostic or
           therapeutic procedures.

      Design is retrospective and prospective registry study.

      Procedures that will be captured include:

        1. EUS-Coils placement

        2. EUS Glue injection

        3. EUS-Fiducial placement

        4. EUS-Neurolysis

        5. EUS-Stent placement

        6. EUS-alcohol injection

        7. EUS-fluid collection, abscess or cavity drainage

        8. EUS guided ductal drainage

        9. EUS-guided Ablation

       10. EUS-guided anastomosis 11. EUS Guided ERCP for gallbladder, pancreatic duct or biliary
           duct drainage
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopic Ultrasound (EUS) Guided Endoscopic retrograde cholangiopancreatography (ERCP) has
      become a therapeutic intervention for the management of biliary obstruction or pancreatic
      strictures related to chronic pancreatitis or other diseases. Successful biliary or
      pancreatic cannulation can be achieved in 90 to 97%. Failure to obtain biliary access can be
      related to operator experience, peri-ampullary diverticula, prior surgery (e.g., Billroth II
      anatomy), tumor involvement of the ampulla, biliary sphincter stenosis and impacted stones.
      In experienced hands, pancreatic duct cannulation fails in less than 10% of cases. This is
      primarily related to surgically altered anatomy or inflammation. Referral to a tertiary care
      center , percutaneous intrahepatic cholangiography (PTC) for biliary decompression , and
      surgical intervention are typically offered after a failed ERCP. Percutaneous intrahepatic
      cholangiography with subsequent percutaneous or endoscopic drainage has a morbidity of up to
      32%. Surgery can also be associated with significant morbidity and mortality.

      Endoscopic ultrasound (EUS) allows detailed imaging of the regional anatomy by approximating
      the frequency transducer to the region of interest. With the evolution of linear array and
      the ability to direct a needle within the field of interest, the therapeutic potential of EUS
      has reached new levels beyond fine needle aspiration (FNA), celiac plexus blocks and drainage
      of cystic lesions. The biliary and pancreatic systems, being in close proximity to the
      gastric or duodenal lumen, are a logical target for EUS in cases not accessible by ERCP.
      EUS-assisted cholangiopancreatography was described a decade ago. In order to validate these
      procedures and broaden its use beyond tertiary centers, it is crucial to understand its
      efficacy and success rate. The objective of the study is to evaluate retrospectively and
      prospectively the efficacy and safety of EUS-Guided ERCP procedures for the diagnosis and
      treatment of pancreatico-biliary disorders.

      The purpose of this registry is to record information and evaluate the impact of EUS-Guided
      ERCP on the management of pancreatico-biliary disorders. The registry will evaluate efficacy,
      safety and technical success of the EUS-Guided ERCP procedures.

      The involvement of multi-international sites is crucial- as the advanced endoscopists outside
      US are attempting similar complex EUS-Guided ERCPs for complicated pancreatico-biliary cases
      as their counterparts in US. However, because of the non-existence of a registry, these cases
      are often reported as isolated case series with remarkable technical similarities to case
      series in other countries.

      The registry hopes to combine all such comparable cases and collect enough relevant data for
      statistical analyses.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>3 years</time_frame>
    <description>Documentation of Safety- Number of Participants with Adverse Events; Type, frequency and intensity of adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy</measure>
    <time_frame>3 years</time_frame>
    <description>Documentation of efficacy: Technical and clinical success rates.
Technical Success rate will be derived from reported success or failure of technical feasibility and conduction of a specific EUS Guided ERCP procedure for a pancreatico-biliary condition.
Clinical success rate will be derived from reported of clinical success hallmarks such as biliary or pancreatic drainage, reduction in total bilirubin, formation of a fistula, immediate and eventual alleviation of symptoms or complaints within a specific period of time, etc. for that particular pancreatico-biliary disorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival duration</measure>
    <time_frame>3 years</time_frame>
    <description>Documentation of response rates and overall survival duration.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Bile Duct Cancer</condition>
  <condition>Biliary Stricture</condition>
  <condition>Biliary Obstruction</condition>
  <condition>Stent Obstruction</condition>
  <condition>Proximal Duct Stricture</condition>
  <condition>Distal Duct Stricture</condition>
  <condition>Ampullary Cancer</condition>
  <condition>Biliary Sphincter Stenosis</condition>
  <condition>Impacted Stones</condition>
  <condition>Chronic Pancreatitis</condition>
  <condition>Peri-ampullary Diverticula</condition>
  <condition>Altered Anatomy</condition>
  <arm_group>
    <arm_group_label>EUS guided ERCP procedure group</arm_group_label>
    <description>Subjects who will undergo Endoscopic Ultrasound (EUS) guided Endoscopic retrograde cholangiopancreatography (ERCP) procedures for their pancreatico-biliary conditions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS guided ERCP</intervention_name>
    <description>Endoscopic ultrasound guided (EUS) endoscopic retrograde cholangiopancreatography (ERCP)</description>
    <arm_group_label>EUS guided ERCP procedure group</arm_group_label>
    <other_name>EUS ERCP</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who has undergone Endoscopic Ultrasound (EUS) guided Endoscopic retrograde
        cholangiopancreatography (ERCP) procedure for diagnosis or treatment of a
        pancreatico-biliary disorder.

        Above 18 years of age.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient who has undergone EUS-guided ERCP (Endoscopic Retrograde
             Cholangiopancreatography)for diagnosis or treatment of a pancreatico-biliary disorder.

          -  Above 18 years of age.

        Exclusion Criteria:

          -  Any subject who has not undergone Endoscopic Ultrasound (EUS) guided Endoscopic
             retrograde cholangiopancreatography (ERCP).

          -  Below 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Kahaleh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Kahaleh, MD</last_name>
      <phone>646-962-4797</phone>
      <email>mkahaleh@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Monica Gaidhane, MPH</last_name>
      <phone>646-962-4796</phone>
      <email>mog2012@med.cornell.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michel Kahaleh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prof. Dr. Everson L.A. Artifon</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>01246-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Everson LA Artifon, MD</last_name>
      <phone>3061-7345</phone>
      <email>eartifon@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Everson LA Artifon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2012</study_first_posted>
  <last_update_submitted>February 16, 2017</last_update_submitted>
  <last_update_submitted_qc>February 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Weill Medical College of Cornell University</investigator_affiliation>
    <investigator_full_name>Michel Kahaleh</investigator_full_name>
    <investigator_title>Chief, Advanced Endoscopy</investigator_title>
  </responsible_party>
  <keyword>Cholangiocarcinoma</keyword>
  <keyword>Pancreatic Cancer</keyword>
  <keyword>Bile Duct Cancer</keyword>
  <keyword>Biliary Stricture</keyword>
  <keyword>Biliary obstruction</keyword>
  <keyword>Stent obstruction</keyword>
  <keyword>Proximal duct stricture</keyword>
  <keyword>Distal duct stricture</keyword>
  <keyword>Ampullary Cancer</keyword>
  <keyword>Biliary sphincter stenosis</keyword>
  <keyword>Impacted stones</keyword>
  <keyword>Chronic pancreatitis</keyword>
  <keyword>Peri-ampullary diverticula</keyword>
  <keyword>Altered anatomy</keyword>
  <keyword>Endoscopic ultrasound</keyword>
  <keyword>Endoscopic Retrograde Cholangiopancreatography</keyword>
  <keyword>Multicenter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
    <mesh_term>Bile Duct Neoplasms</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Tooth, Impacted</mesh_term>
    <mesh_term>Diverticulum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

